CTLT

Catalent, Inc.

57.10 USD
-0.09 (-0.16%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Catalent, Inc. stock is up 4.75% since 30 days ago. The next earnings date is May 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
07 Feb 20:51 16 Feb, 2024 40.00 CALL 30 155
08 Feb 18:13 15 Mar, 2024 60.00 CALL 2269 1171
08 Feb 18:18 15 Mar, 2024 60.00 CALL 1350 1171
08 Feb 19:28 15 Mar, 2024 60.00 CALL 2002 1171
12 Feb 14:32 16 Jan, 2026 57.50 CALL 50 59
15 Feb 15:47 19 Apr, 2024 65.00 CALL 1600 62
21 Feb 19:38 15 Mar, 2024 60.00 CALL 600 5506
22 Feb 16:35 19 Apr, 2024 55.00 PUT 600 71
22 Feb 16:36 19 Apr, 2024 57.50 PUT 473 315
29 Feb 16:55 15 Mar, 2024 57.50 PUT 1885 4150

About Catalent, Inc.

Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products. It operates through four segments: Biologics and Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The company serves pharmaceutical, biotechnology, consumer health companies; and companies in other healthcare market segments such as animal health and medical devices.

  • RBC Capital
    Tue Feb 20, 10:25
    hold
    confirm
  • RBC Capital
    Tue Feb 6, 06:15
    hold
    downgrade
  • UBS
    Tue Feb 6, 06:04
    hold
    downgrade
  • Stephens & Co.
    Tue Feb 6, 05:52
    hold
    downgrade